Evidence map›Paper›PMID 38437609›Full record

ArticleHealth affairs (Project Hope)2024

PrEP Discontinuation In A US National Cohort Of Sexual And Gender Minority Populations, 2017-22.

Yan Guo, Drew A Westmoreland, Alexa D'Angelo, Chloe Mirzayi, Michelle Dearolf, Pedro B Carneiro, Meredith Ray, David W Pantalone, Adam W Carrico, Viraj V Patel and 5 more

Abstract read
In one paragraph

Article in Health affairs (Project Hope), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 3 countries.

Yan GuoYan Guo, City University of New York, New York, New York.
Drew A WestmorelandDrew A. Westmoreland, University of Florida, Gainesville, Florida.
Alexa D'AngeloAlexa D'Angelo, City University of New York.
Chloe MirzayiChloe Mirzayi, City University of New York.
Michelle DearolfMichelle Dearolf, City University of New York.
Pedro B CarneiroPedro B. Carneiro, City University of New York.
Meredith RayMeredith Ray, University of Memphis, Memphis, Tennessee.
David W PantaloneDavid W. Pantalone, University of Massachusetts Boston, Boston, Massachusetts.
Adam W CarricoAdam W. Carrico, Florida International University, Miami, Florida.
Viraj V PatelViraj V. Patel, Albert Einstein College of Medicine, New York, New York.
Sarit A GolubSarit A. Golub, City University of New York.
Sabina HirshfieldSabina Hirshfield, SUNY Downstate Health Sciences University, New York, New York.
Donald HooverDonald Hoover, Rutgers University, New Brunswick, New Jersey.
Denis NashDenis Nash, City University of New York.
Christian GrovChristian Grov (Christian.Grov@sph.cuny.edu), City University of New York.
City University of New York · USAlbert Einstein College of Medicine · USAlexion Pharma (Switzerland) · CHBoston University · USFlorida International University · USHospital San Pedro · ESMid-America Christian University · USRutgers, The State University of New Jersey · USScience Club · USSUNY Downstate Health Sciences University · USUniversity of Florida · USUniversity of Memphis · US

Funding

Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Kathryn M. Anastos · 2017 to 2026
$28.3M
Following a U.S. National Cohort of Vulnerable Men to Improve HIV Prevention and CareUH3AI133675 · NIAID · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI GROV, CHRISTIAN · 2019 to 2021
$6.9M
Following a U.S. National Cohort of Vulnerable Men to Improve HIV Prevention and CareUG3AI133675 · NIAID · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI GROV, CHRISTIAN · 2017 to 2018
$2.6M
The Impact of Alcohol on PrEP Adherence in Vulnerable MenK01AA029047 · NIAAA · UNIVERSITY OF FLORIDA · PI WESTMORELAND, DREW ANNE · 2020 to 2024
$940k
NIAAA NIH HHS K01 AA029047NIAID NIH HHS P30 AI124414NIAID NIH HHS UG3 AI133675NIAID NIH HHS UH3 AI133675
6 · The paper itself

Abstract

In the US, sexual and gender minority populations are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a key prevention method, but its effectiveness relies on consistent usage. Our four-year national cohort study explored PrEP discontinuation among sexual and gender minority people who initiated PrEP. We found a high annual rate of discontinuation (35-40 percent) after PrEP initiation. Multivariable analysis with 6,410 person-years identified housing instability and prior history of PrEP discontinuation as predictors of discontinuation. Conversely, older age, clinical indication for PrEP, and having health insurance were associated with ongoing PrEP use. To promote sustained PrEP use, strategies should focus on supporting those at high risk for discontinuation, such as younger people, those without stable housing or health insurance, and prior PrEP discontinuers.

Indexed as

Sexual and Gender MinoritiesSexual BehaviorCognitionCohort StudiesHumansMinority Groups

Identifiers

PMID38437609
PMCPMC13034158
OpenAlexW4392383797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.